Search results
Prostate cancer: Supplement, keto diet may boost immunotherapy
Medical News Today· 2 days agoAbout 13% of cisgender men around the world will receive a prostate cancer diagnosis in their...
Why selling to Novartis made sense for Mariana
BioPharma Dive via Yahoo Finance· 17 hours agoNovartis’ success with Pluvicto in prostate cancer has motivated others, Mariana among them, to follow into the field. “We began thinking in mid-2020...
Angle to Develop Prostate Cancer Liquid Biopsy Assay for AstraZeneca
GenomeWeb News· 16 hours agoAngle announced on Friday that it has signed a supplier agreement with AstraZeneca to develop an androgen receptor (AR) assay to assess prostate cancer ...
New Trials in Prostate Cancer: Could Your Patient Benefit?
Medscape· 5 days agoPerhaps one of your patients could benefit from a clinical trial that has recently opened in ...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
NBC 17 Raleigh· 13 hours agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment with ERLEADA® (apalutamide) and androgen deprivation therapy (ADT ...
Angle PLC Announces New Commercial Agreement with Large Pharma
Digital Journal· 24 hours agoANGLE commissioned to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies GUILDFORD, SURREY / ACCESSWIRE / May ...
Men on hair-loss drug warned of sexual and psychiatric side effects
The Telegraph via Yahoo News· 4 days agoIt has also ordered suppliers of finasteride to now include a patient alert card in packs of the ...
Swing Against Cancer 2024 breaks records, raises $220,000 for research
The Desert Sun via Yahoo News· 22 hours agoAfter presenting an engaging audience participation exercise about statistics in cancer research and...
Trelstar dosage: Form, strengths, how to use, and more
Medical News Today· 3 days agoTrelstar (triptorelin pamoate) is a brand-name drug that’s prescribed for advanced prostate cancer...
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032
FOX 4 Kansas City· 13 hours agoAccording to a "highly troubling" new study, the rising number of cancer cases in young people is...